RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 7 analysts with an average price target of $8.67. This is a potential upside of $11.35 (187.09%) from yesterday's end of day stock price of $3.02.

Rocket Pharmaceuticals's activity chart (see below) currently has 118 price targets and 123 ratings on display. The stock rating distribution of RCKT is 71.43% BUY, 21.43% HOLD and 7.14% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.17% with an average time for these price targets to be met of 122.53 days.

Highest price target for RCKT is $15, Lowest price target is $3, average price target is $8.67.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 16-Sep-2026. First documented stock forecast 28-Jul-2015.

Currently out of the existing stock ratings of RCKT, 10 are a BUY (71.43%), 3 are a HOLD (21.43%), 1 are a SELL (7.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 24-Jul-2025

$9

$5.63 (167.06%)

8 days ago
(16-Sep-2026)

0/17 (0%)

$5.52 (158.62%)

Buy Since 01-Nov-2022

$15

$11.63 (345.10%)

$15

8 days ago
(16-Sep-2026)

0/5 (0%)

$11.52 (331.03%)

Buy Since 06-Nov-2019

$11

$7.63 (226.41%)

$11

23 days ago
(01-Sep-2026)

3/16 (18.75%)

$7.27 (194.91%)

142

Buy Since 18-Nov-2025

$9

$5.75 (176.92%)

$8

5 months 25 days ago
(30-Mar-2026)

0/3 (0%)

$5.55 (160.87%)

Sell Since 02-Mar-2026

$3

$-0.25 (-7.69%)

$13

6 months 22 days ago
(02-Mar-2026)

1/5 (20%)

$-1.97 (-39.64%)

78

Show more analysts

Please expand the browser size to see the chart

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 123 days for the stock forecasts to be reached, with an average price target met ratio of 33.17%.

Which analyst most recently updated their price target on RCKT (Rocket Pharmaceuticals)?

Gil Blum

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Gil Blum works at NEEDHAM and has 22 price targets and 13 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Corey Davis with the highest potential upside of $83.86

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Andrew Tsai with the lowest potential downside of -$0.87

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?